Last reviewed · How we verify
NCT05794217
A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
trial testing This is a non-interventional study in Rare Diseases in 20,000 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Sanguine Biosciences |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 20,000 |
| Start date | 28 September 2022 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- This is a non-interventional study
Conditions studied
- Rare Diseases — all drugs for Rare Diseases →
Sponsor
Sanguine Biosciences
Who can join
Adults 18 to 89, any sex, with Rare Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To collect, preserve, and distribute annotated leukopak biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions. This protocol will be utilized to collect research grade products that are not meant for transfusion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05794217
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of This is a non-interventional study
Trials testing the same drug.
- NCT05932043 — Development of the Work In Progress Questionnaire · unknown
- NCT04804566 — Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients · completed
- NCT06793254 — Translation, Cultural Adaptation and Validation of the Italian Version of Functional Rating Index in Patients With Chron · completed
- NCT05118217 — Microvascular Dysfunction in Diabetic Peripheral Neuropathy · unknown
- NCT04637113 — Singapore's Health Outcomes After Critical Illness in Kids · completed
Other recruiting trials for Rare Diseases
Currently open trials in the same condition.
- NCT06595940 — Genetic Analysis of Uncommon Disease Presentations in Non-US Populations · recruiting
- NCT07247279 — Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia · recruiting
- NCT07102966 — Genetic Study to Determine the Cause of Birth Defects in Newborns in Texas · NA · recruiting
- NCT06856902 — BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe · NA · recruiting
- NCT06926127 — Genomic Profiling of Genetic and Rare Diseases · NA · recruiting
Other Sanguine Biosciences trials
Trials by the same sponsor.
- NCT05910853 — Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia · terminated
- NCT05915897 — Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD) · terminated
- NCT05915910 — Prospective Collection of Biospecimen in Pediatric Patients and Adult Guardians Diagnosed With Glycogen Storage Disease · terminated
- NCT05821582 — Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens · withdrawn
- NCT05773196 — Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05794217 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sanguine Biosciences
- Last refreshed: 6 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05794217.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing